GlassScriptPhysician profile
Debra Lawrence
NPI 1184629388
$3,675.86
in general payments reported to CMS, 2019-2025
40 companies · $464 in 2025
The $464 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $282 · 2021: $649 · 2022: $751 · 2023: $495 · 2024: $467 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,386 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.16 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $349.47 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $302.52 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $296.84 | 2019-2025 | |
| Pfizer INC. | $272.76 | 2022-2024 | |
| Merz North America, INC. | $215.47 | 2019 | |
| Hologic Sales and Service, LLC | $183.19 | 2019-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Evofem Biosciences, INC. | $178.62 | 2021-2022 | |
| Biogen, INC. | $168.40 | 2024-2025 | Zurzuvae |
| Avion Pharmaceuticals | $163.91 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $155.74 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $121.02 | 2021-2024 | Slynd |
| Astellas Pharma US INC | $113.84 | 2023-2025 | Veozah, Myrbetriq |
| Amgen INC. | $103.54 | 2019-2025 | Evenity, Prolia |
| Allergan, INC. | $100.00 | 2019-2021 | |
| Coopersurgical, INC. | $89.20 | 2020-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.